Jian Dong
Kunming Medical University
17 Papers
55 Citations
Jian Dong is an academic researcher from Kunming Medical University. The author has contributed to research in topics: Cancer & Familial adenomatous polyposis. The author has an hindex of 6, co-authored 15 publications.
Chat about Author
Papers
Long Noncoding RNA CRNDE/PRC2 Participated in the Radiotherapy Resistance of Human Lung Adenocarcinoma Through Targeting p21 Expression.
TL;DR: The data suggest that CRNDE may function as an oncogene by modulating p21, finally contributing to the radioresistant phenotype formation of LAD cells.
72
The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer
Hongchao Jiang,Ceshi Chen,Qiangming Sun,Jing Wu,Lijuan Qiu,Change Gao,Weiqing Liu,Jun Yang,Nie Jun,Jian Dong +9 more
TL;DR: The results showed that Sema4D may represent a novel therapeutic target for human breast cancer, as it was expressed at higher levels in breast cancer cell lines compared with the normal human breast epithelial cell lines, especially in MDA-MB-231 and MDA -MB-468 cells.
A Novel Prognostic Prediction Model for Colorectal Cancer Based on Nine Autophagy-Related Long Noncoding RNAs.
Guoqiang Xu,Mei Yang,Qiaoli Wang,Liufang Zhao,Sijin Zhu,Lixiu Zhu,Tianrui Xu,Ruixue Cao,Cheng Li,Qiuyan Liu,Wei Xiong,Yan Su,Jian Dong +12 more
TL;DR: In this article, an autophagy-related lncRNA (ARlncRNA)-based bioinformatics model is used for predicting survival and facilitating clinical treatment of colorectal cancer.
PD-1 inhibitors dependent CD8 + T cells inhibit mouse colon cancer cell metastasis
TL;DR: It is suggested that PD-1 inhibitors rely on CD8+ T cells to exert anti-tumor immunity in colon cancer, and anti-PD-1 treatment cannot exert these roles when CD8 is depleted.
Microarray based analysis of gene regulation by mesenchymal stem cells in breast cancer
TL;DR: MSCs were demonstrated to exhibit potentially beneficial effects for breast cancer therapy and the screened DEGs, particularly in PPI network modules, may be the potential target genes of MSC therapy for Breast cancer.